Leg Fluid Shift in Patients With Chronic Heart Failure and Obstructive or Central Sleep Apnea (NCT03092388) | Clinical Trial Compass
CompletedNot Applicable
Leg Fluid Shift in Patients With Chronic Heart Failure and Obstructive or Central Sleep Apnea
Germany40 participantsStarted 2015-02
Plain-language summary
This study aims to investigate the influence of a potential leg fluid shift (LFS) in patients with chronic heart failure (CHF) and obstructive sleep apnea (OSA) or central sleep apnea (CSA).
Who can participate
Age range18 Years
SexMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Chronic Heart Failure
* reduced left ventricular ejection fraction (LVEF) ≤ 45%
* NYHA I - IV
Exclusion Criteria:
* current existing sleep apnoea breathing therapy
* significant chronic obstructive pulmonary disease (COPD) Tiffenau-Index: \<70%
* respiratory insufficiency with need for a long time oxygen therapy
* hypercapnic state in rest at day time
* acute myocardial infarction at moment of study
* instable angina pectoris at moment of study
* cardiac surgery in last twelve weeks
* stroke or TIA in last twelve weeks
* implantable cardioverter-defibrillator, if there is no security clearance of the fabricator
* chronic kidney disease \> Stage III
What they're measuring
1
∆ Leg Fluid Shift (LFS)
Timeframe: one night
Trial details
NCT IDNCT03092388
SponsorHeart and Diabetes Center North-Rhine Westfalia